Pharma Journalist -

PTC Therapeutics has withdrawn its resubmitted New Drug Application for Translarna (ataluren) to treat nonsense mutation Duchenne muscular dystrophy after receiving review feedback from…
Read More...

China-based biotech developer Shanghai Ark Biopharmaceutical Co., Ltd. has received clearance from the U.S. Food and Drug Administration to begin a U.S. clinical study of its…
Read More...

French pharmaceutical group Sanofi announced a leadership transition after its board decided not to renew the mandate of Chief Executive Officer Paul Hudson. His final day leading the…
Read More...

Biotechnology company Amgen has received authorization from the European Commission for UPLIZNA as an add-on therapy for adults with generalized myasthenia gravis (gMG) who test…
Read More...

Pharmaceutical giant Merck & Co., Inc. — known internationally as MSD — has received U.S. regulatory approval for expanded use of its immunotherapy KEYTRUDA and the newer…
Read More...

Cancer-focused biotechnology company Citius Oncology, Inc. has entered an exclusive distribution agreement with international healthcare services group Uniphar to expand patient access…
Read More...

Biopharmaceutical company Madrigal Pharmaceuticals, Inc. has signed an exclusive global licensing agreement with Suzhou Ribo Life Science Co. Ltd. and its subsidiary Ribocure…
Read More...

Private equity firm Ampersand Capital Partners has announced the acquisition of contract development and manufacturing provider Purna Pharmaceuticals, signaling a strategic move to…
Read More...

A new collaboration between U.S. cell-therapy manufacturer Kincell Bio and biotechnology innovator RegCell aims to accelerate the clinical development of a next-generation…
Read More...

Clinical-stage biotechnology company Insilico Medicine and pharmaceutical commercialization group China Medical System Holdings have announced a multi-project collaboration aimed at…
Read More...